Pure ocular anti-musk myasthenia under no immunosuppressive treatment

Muscle and Nerve

Volumn 48, Issue 3, 2013, Pages 464-464

  Zouvelou, Vasiliki ^a   Papathanasiou, Athanasios ^a   Koros, Christos ^a   Rentzos, Michael ^a   Zambelis, Thomas ^a   Stamboulis, Eleftherios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; PYRIDOSTIGMINE;

ADULT; ANTIBODY TITER; CASE REPORT; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CIRCADIAN RHYTHM; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DELTOID MUSCLE; DIPLOPIA; DISEASE COURSE; DISEASE DURATION; ELECTROMYOGRAPHY; EXTRAOCULAR MUSCLE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; MEDICAL HISTORY; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PTOSIS; REMISSION;

ANTIBODIES; BLEPHAROPTOSIS; DIPLOPIA; HUMANS; MALE; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; YOUNG ADULT;

EID: 84883052457     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23847     Document Type: Letter

References (13)

1. AAEM Quality Assurance Committee: practice parameter for repetitive nerve stimulation and single-fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Summary statement. Muscle Nerve 2001;24:1236-1238.
2. Oh SJ. Muscle -specific receptor tyrosine kinase antibody positive myasthenia gravis current status. J Clin Neurol 2009;5:53-64.
3. Guptill JT, Sanders DB, Evoli A. Anti-MuSK antibody Myasthenia Gravis: Clinical findings and response to treatment in two large cohorts. Muscle Nerve 2011;44:36-40.
4. Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003;60:1978-1980.
5. McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004;55:580-584.
6. Zhou L, McCoville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, et al. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve 2004;30:55-60.
7. Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-2311.
8. Lee JY, Sung JJ, Cho JY, Oh DH, Kim HJ, Park JH, et al. MuSK antibody-positive seronegative myasthenia gravis in Korea. J Clin Neurosci 2006;13:353-355.
9. Niks EH, Kuks JB, Verschuuren JJ. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands. J Neurol Neurosurg Psychiatry 2005;76:714-718.
10. Caress JB, Hunt CH, Batish SD. Anti-MuSK myasthenia gravis presenting with purely ocular findings. Arch Neurol 2005;62:1002-1003.
11. Bennett DL, Mills KR, Riordan-Eva P, Barnes PR, Rose MR. Anti-MuSK antibodies in a case of ocular myasthenia gravis. J Neurol Neurosurg Psychiatry 2006;77:564-565.
12. Hanisch F, Eger K, Zierz S. MuSK-antibody positive pure ocular myasthenia gravis. J Neurol 2006;253:659-660.
13. Chan JW, Orrison WW. Ocular myasthenia:a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy. Br J Ophthalmol 2007;91:842-843.